Ibiglustat, CAS [[1401090-53-6]]

Produktübersicht

• Artikelname: Ibiglustat, CAS [[1401090-53-6]]
• Artikelnummer: TGM-T4473
• Hersteller Artikelnummer: T4473
• Alternativnummer: TGM-T4473-1MLX10MM(INDMSO),TGM-T4473-1MG,TGM-T4473-5MG,TGM-T4473-10MG,TGM-T4473-25MG,TGM-T4473-50MG,TGM-T4473-100MG
• Hersteller: TargetMol
• Kategorie: Biochemikalien
• Alternative Synonym: GZ402671 , SAR402671 , Venglustat

Produktbeschreibung

Ibiglustat (GZ402671) is a potent and selective Glucosylceramide synthase inhibitor and ceramide glucosyltransferase inhibitor. Ibiglustat blocks the formation of glucosylceramide (GL-1), a key intermediate in the synthesis of GL-3. Ibiglustat is potentially useful for treating Fabry disease. Fabry disease is a rare lysosomal storage disorder, which results in abnormal tissue deposits of a particular fatty substance called globotriaosylceramide (GL-3 or Gb3) throughout the body.

Produkteigenschaften

• Molekulargewicht: 389.49
• Reinheit: 97.97%
• CAS Nummer: [1401090-53-6]
• Formel: C20H24FN3O2S
• Target-Kategorie: Transferase

Bilder

T4473